<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31">
 <label>31</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fisher</surname>
    <given-names>C. J.</given-names>
   </name>
   <name>
    <surname>Dhainaut</surname>
    <given-names>J. F.</given-names>
   </name>
   <name>
    <surname>Opal</surname>
    <given-names>S. M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. phase III rhIL-1ra sepsis syndrome study group</article-title>
  <source>
   <italic toggle="yes">JAMA: The Journal of the American Medical Association</italic>
  </source>
  <year>1994</year>
  <volume>271</volume>
  <issue>23</issue>
  <fpage>1836</fpage>
  <lpage>1843</lpage>
  <pub-id pub-id-type="doi">10.1001/jama.271.23.1836</pub-id>
  <pub-id pub-id-type="pmid">8196140</pub-id>
 </element-citation>
</ref>
